Immugen BioPharma, Inc.
Biotechnology ResearchFlorida, United States2-10 Employees
Our mission is to harness the endocannabinoid system for women's health based on results from an NIH funded grant.
Innovative Focus Immugen BioPharma specializes in harnessing the endocannabinoid system for women's health, indicating a niche market focus that can attract healthcare providers and wellness companies interested in cutting-edge biotechnologies.
Emerging Market Potential With a revenue range of 1 to 10 million dollars and a small team, there is significant growth opportunity as the company expands its research capabilities and commercial reach within the biotech and healthcare sectors.
Technology Utilization The company's use of modern cloud and web technologies like Google Cloud, React, and Wix suggests a digitally agile organization, which can be leveraged for targeted digital marketing and partnership collaborations.
Funding Opportunities While specific funding data is not available, ongoing NIH-backed research indicates potential for grant support or partnerships with larger biotech firms, opening avenues for co-investment and collaborative projects.
Competitive Differentiation Focusing on women's health through endocannabinoid system research positions Immugen BioPharma distinctively in a competitive biotech landscape dominated by larger players, making it an attractive candidate for strategic alliances and licensing opportunities.
Immugen BioPharma, Inc. uses 8 technology products and services including Wix, Open Graph, Wix eCommerce, and more. Explore Immugen BioPharma, Inc.'s tech stack below.
| Immugen BioPharma, Inc. Email Formats | Percentage |
| First.Last@immugen.com | 33% |
| FiLast@immugen.com | 17% |
| First.Last@immugen.com | 33% |
| FiLast@immugen.com | 17% |
Biotechnology ResearchFlorida, United States2-10 Employees
Our mission is to harness the endocannabinoid system for women's health based on results from an NIH funded grant.
Immugen BioPharma, Inc.'s revenue is estimated to be in the range of $1M$10M
Immugen BioPharma, Inc.'s revenue is estimated to be in the range of $1M$10M